Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR) - PubMed (original) (raw)

Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)

Evan M Kroh et al. Methods. 2010 Apr.

Erratum in

Methods. 2010 Nov;52(3):268

Abstract

MicroRNAs (miRNAs) are small (approximately 22 nt) RNAs that play important roles in gene regulatory networks by binding to and repressing the activity of specific target mRNAs. Recent studies have indicated that miRNAs circulate in a stable, cell-free form in the bloodstream and that the abundance of specific miRNAs in plasma or serum can serve as biomarkers of cancer and other diseases. Measurement of circulating miRNAs as biomarkers is associated with some special challenges, including those related to pre-analytic variation and data normalization. We describe here our procedure for qRT-PCR analysis of circulating miRNAs as biomarkers, and discuss relevant issues of sample preparation, experimental design and data analysis.

PubMed Disclaimer

Cited by

Tissue specific expression of extracellular microRNA in human breast cancers and normal human breast tissue in vivo.
Abrahamsson A, Dabrosin C. Abrahamsson A, et al. Oncotarget. 2015 Sep 8;6(26):22959-69. doi: 10.18632/oncotarget.4038. Oncotarget. 2015. PMID: 26008976 Free PMC article.
MicroRNAs as potential biomarkers for noninvasive detection of fetal trisomy 21.
Lim JH, Lee DE, Kim SY, Kim HJ, Kim KS, Han YJ, Kim MH, Choi JS, Kim MY, Ryu HM, Park SY. Lim JH, et al. J Assist Reprod Genet. 2015 May;32(5):827-37. doi: 10.1007/s10815-015-0429-y. Epub 2015 Mar 8. J Assist Reprod Genet. 2015. PMID: 25749789 Free PMC article.
Identification of suitable endogenous controls for gene and miRNA expression studies in irradiated prostate cancer cells.
Lawlor H, Meunier A, McDermott N, Lynch TH, Marignol L. Lawlor H, et al. Tumour Biol. 2015 Aug;36(8):6019-28. doi: 10.1007/s13277-015-3278-5. Epub 2015 Mar 7. Tumour Biol. 2015. PMID: 25750034
Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients.
Stückrath I, Rack B, Janni W, Jäger B, Pantel K, Schwarzenbach H. Stückrath I, et al. Oncotarget. 2015 May 30;6(15):13387-401. doi: 10.18632/oncotarget.3874. Oncotarget. 2015. PMID: 26033453 Free PMC article. Clinical Trial.
Circulating miR-134 is a potential biomarker for diagnosis and monitoring of major depressive disorder.
Chen X, Liu X, Zuo X, Cheng C, Huang W, Xie P. Chen X, et al. Int J Clin Exp Pathol. 2020 Aug 1;13(8):2082-2091. eCollection 2020. Int J Clin Exp Pathol. 2020. PMID: 32922604 Free PMC article. Retracted.

References

1. Carthew RW, Sontheimer EJ. Cell. 2009;136:642–55. - PMC - PubMed
1. Flynt AS, Lai EC. Nat Rev Genet. 2008;9:831–42. - PMC - PubMed
1. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. Proc Natl Acad Sci USA. 2008;105:10513–8. - PMC - PubMed
1. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY. Cell Res. 2008;10:997–1006. - PubMed
1. Chim SS, Shing TK, Hung EC, Leung TY, Lau TK, Chiu RW, Lo YM. Clin Chem. 2008;54:482–90. - PubMed

Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR) - PubMed (original) (raw)